Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eledon Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (right to buy) | 267K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELDN | Eledon Pharmaceuticals, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Chief Financial Officer |
ELDN | Eledon Pharmaceuticals, Inc. | May 1, 2023 | 1 | $0 | 4 | May 2, 2023 | Chief Financial Officer |
ELDN | Eledon Pharmaceuticals, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 2, 2023 | Chief Financial Officer |
ELDN | Eledon Pharmaceuticals, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Financial Officer |
ELDN | Eledon Pharmaceuticals, Inc. | Jun 11, 2021 | 1 | $88.7K | 4 | Jun 14, 2021 | CHIEF FINANCIAL OFFICER |